BeNa Culture Collection
Home
Cell Products
Microbe Products
Download
Quality Control Products
News
My Account
About Us
On August 1, 2024, MUTU, Indonesia's first test company, visited and inspected BNCC. Our company welcomes the arrival of foreign friends and hope to reach cooperation in the field of microbiology through this exchange.
We took them to our microbiology lab and they were interested in our laboratory instruments and equipment. BNCC has been at the forefront of microbial and cell strains production and research since our establishment in 2010. It has a 17025 certified laboratory. Our comprehensive product portfolio covers food, pharmaceuticals, agriculture, and industrial fields, serving over 3000 laboratories worldwide.
At the forum, the two companies had an in-depth discussion on the cooperation model. We offer a wide range of possibilities for future cooperation
BNCC was founded in 2010. It is a high-tech enterprise focusing on scientific research of cells, microbial species and standard materials, integrating research and development, production and application. With 10000 square meters of floorage ,4000 square meters of laboratory area,and 2000 squares meters of BSL-2 laboratory, BNCC has complete infrastructure for strain cell collection and management,such as industrial microbial strain center, tumor cell center, virus center,fungus and bacteria preparation center,laboratories for PCR nucleic acid detection and sequencing.
BNCC is actively seeking global agents and distributor to join our ranks. If you are willing to join BNCC, please feel free to contact us for more details.
In order to strengthen corporate team building, improve team cohesion and centripetal force, and promote communication among employees, from October 3rd to 4th, all Beina employees carried out team building activities.
Glioblastoma (GBM) is one of the most aggressive and lethal types of primary brain and central nervous system (CNS) tumors. After surgery to remove the tumor, glioblastoma patients are usually treated with radiation therapy and the chemotherapy drug Temozolomide (TMZ).
Various bacteria have their own unique enzyme systems, so their ability to decompose substrates is different, and their metabolites are also different.